- Prev. close
- ¥2,654
- Volume
- 7.6M
Stock and sector context
Healthcareoutflow- Sector comparison
- Of 3 covered Healthcare stocks in Japanese, 2 fell; the average change was -0.71%. Daiichi Sankyo moved in the same direction at -1.15%. Estimated sector flow was outflow.
- Variables to watch
- Drug approvals and trial resultsDrug pricing policyUS interest ratesUSD/JPY
- Risks to check
- -37% below the high, the downtrend may continue
- Clinical trial failure
- Drug pricing pressure
This compares price changes among covered stocks in the same market. It does not establish why prices moved. Variables and risks are sector reference lists.
Why a candidate
Match 54/100The match score marks how many conditions overlap on a 0 to 100 scale: the 52-week range, valuation metrics, price change and volume. It is not a probability of rising or a forecast return.
Today's read
Daiichi Sankyo scores 54 out of 100 on today's InverseOne match ranking, 5 of 30 in the Japanese large-cap universe. The gap to its 52-week high is 59%. Today's move of -1.15% came with money flowing out; the broader Healthcare sector flow is worth checking. Scores are estimates built from price and volume, a starting point for research rather than a trading signal.
Data basis: 2026-10-09 close, 10-14 00:20 KST updated, For reference only, not advice
Same-sector stocks, Healthcare
Talk about this stock
Today's talking points
- It sits low in its 52-week range (13).
- It is 59% below its 52-week high.
Three months out, which way do you see it?
Nobody has answered yet. Sign in to be the first.
These are answers picked by members, not investment advice.
These figures are reference estimates built from price and volume: a starting point for narrowing down ideas, not a buy or sell signal.